CTT PHARMACEUTICAL HOLDINGS, INC.

Mindesta Inc. is a development-stage pharmaceutical technology company focused on drug delivery systems. Operating through its wholly owned subsidiary, CTT Pharmaceuticals, Inc., the company specializes in fast-dissolving oral thin wafers designed to carry pharmaceutical agents. Its primary focus is creating cannabis-infused wafers containing natural or synthetic cannabinoids for pain management and treating the side effects of cancer therapy, offering an alternative to smoking or swallowing pills. The company targets patients requiring fast-acting relief, such as individuals suffering from acute or persistent pain, as well as pediatric and geriatric patients who experience difficulty swallowing conventional medications.

The company is incorporated in Delaware but conducts no business activities in the United States, focusing instead on Canada. It has no proprietary manufacturing facilities and relies on third-party manufacturers to produce its wafers. As of December 31, 2014, the company employs two part-time workers alongside its officers and directors, and does not state a specific city or address for its corporate headquarters.

Summary of the business section of Ctt Pharmaceutical's latest annual report, written by StockData.